Switch to:
Also traded in: Germany, Mexico

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 0.04
MD's Cash-to-Debt is ranked lower than
87% of the 210 Companies
in the Global Medical Care industry.

( Industry Median: 0.26 vs. MD: 0.04 )
Ranked among companies with meaningful Cash-to-Debt only.
MD' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.02  Med: 0.47 Max: 157.27
Current: 0.04
0.02
157.27
Equity-to-Asset 0.52
MD's Equity-to-Asset is ranked higher than
61% of the 205 Companies
in the Global Medical Care industry.

( Industry Median: 0.45 vs. MD: 0.52 )
Ranked among companies with meaningful Equity-to-Asset only.
MD' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.52  Med: 0.74 Max: 0.85
Current: 0.52
0.52
0.85
Interest Coverage 9.06
MD's Interest Coverage is ranked higher than
52% of the 217 Companies
in the Global Medical Care industry.

( Industry Median: 8.17 vs. MD: 9.06 )
Ranked among companies with meaningful Interest Coverage only.
MD' s Interest Coverage Range Over the Past 10 Years
Min: 9.06  Med: 90.58 Max: 294.93
Current: 9.06
9.06
294.93
Piotroski F-Score: 5
Altman Z-Score: 3.01
Beneish M-Score: -2.51
WACC vs ROIC
3.96%
8.93%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 17.96
MD's Operating Margin % is ranked higher than
86% of the 208 Companies
in the Global Medical Care industry.

( Industry Median: 6.49 vs. MD: 17.96 )
Ranked among companies with meaningful Operating Margin % only.
MD' s Operating Margin % Range Over the Past 10 Years
Min: 17.96  Med: 21.89 Max: 24.07
Current: 17.96
17.96
24.07
Net Margin % 10.21
MD's Net Margin % is ranked higher than
78% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 4.33 vs. MD: 10.21 )
Ranked among companies with meaningful Net Margin % only.
MD' s Net Margin % Range Over the Past 10 Years
Min: 10.21  Med: 13.46 Max: 15.84
Current: 10.21
10.21
15.84
ROE % 12.61
MD's ROE % is ranked higher than
61% of the 193 Companies
in the Global Medical Care industry.

( Industry Median: 9.61 vs. MD: 12.61 )
Ranked among companies with meaningful ROE % only.
MD' s ROE % Range Over the Past 10 Years
Min: 12.5  Med: 14.04 Max: 17.59
Current: 12.61
12.5
17.59
ROA % 6.59
MD's ROA % is ranked higher than
71% of the 212 Companies
in the Global Medical Care industry.

( Industry Median: 3.57 vs. MD: 6.59 )
Ranked among companies with meaningful ROA % only.
MD' s ROA % Range Over the Past 10 Years
Min: 6.57  Med: 9.93 Max: 12.09
Current: 6.59
6.57
12.09
ROC (Joel Greenblatt) % 266.48
MD's ROC (Joel Greenblatt) % is ranked higher than
98% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 15.74 vs. MD: 266.48 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
MD' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 266.48  Med: 621.53 Max: 755.09
Current: 266.48
266.48
755.09
3-Year Revenue Growth Rate 17.00
MD's 3-Year Revenue Growth Rate is ranked higher than
82% of the 180 Companies
in the Global Medical Care industry.

( Industry Median: 8.20 vs. MD: 17.00 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
MD' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 6.9  Med: 14.5 Max: 22.4
Current: 17
6.9
22.4
3-Year EBITDA Growth Rate 13.50
MD's 3-Year EBITDA Growth Rate is ranked higher than
66% of the 157 Companies
in the Global Medical Care industry.

( Industry Median: 7.30 vs. MD: 13.50 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
MD' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -1.4  Med: 12.9 Max: 34.6
Current: 13.5
-1.4
34.6
3-Year EPS without NRI Growth Rate 7.90
MD's 3-Year EPS without NRI Growth Rate is ranked higher than
53% of the 131 Companies
in the Global Medical Care industry.

( Industry Median: 6.80 vs. MD: 7.90 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
MD' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -20.2  Med: 12.9 Max: 71.5
Current: 7.9
-20.2
71.5
GuruFocus has detected 3 Warning Signs with Mednax Inc $MD.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» MD's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

MD Guru Trades in Q1 2016

Jim Simons 441,600 sh (New)
Ray Dalio 7,732 sh (New)
Columbia Wanger 1,041,677 sh (New)
Joel Greenblatt 351,118 sh (+32.13%)
Pioneer Investments 262,512 sh (+9.29%)
Mariko Gordon 52,787 sh (+8.74%)
Vanguard Health Care Fund 805,600 sh (unchged)
Chuck Royce Sold Out
Paul Tudor Jones Sold Out
Jeremy Grantham 71,400 sh (-0.42%)
» More
Q2 2016

MD Guru Trades in Q2 2016

Pioneer Investments 315,383 sh (+20.14%)
Vanguard Health Care Fund 805,600 sh (unchged)
Ray Dalio Sold Out
Jeremy Grantham Sold Out
Joel Greenblatt Sold Out
Columbia Wanger 972,106 sh (-6.68%)
Mariko Gordon 43,087 sh (-18.38%)
Jim Simons 252,200 sh (-42.89%)
» More
Q3 2016

MD Guru Trades in Q3 2016

First Pacific Advisors 23,570 sh (New)
Vanguard Health Care Fund 805,600 sh (unchged)
Jim Simons Sold Out
Mariko Gordon Sold Out
Columbia Wanger 847,522 sh (-12.82%)
Pioneer Investments 134,446 sh (-57.37%)
» More
Q4 2016

MD Guru Trades in Q4 2016

Joel Greenblatt 3,834 sh (New)
First Pacific Advisors 36,570 sh (+55.15%)
Vanguard Health Care Fund Sold Out
Columbia Wanger 792,941 sh (-6.44%)
Pioneer Investments 105,515 sh (-21.52%)
» More
» Details

Insider Trades

Latest Guru Trades with MD

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care    NAICS: 621498    SIC: 8093
Compare:OTCPK:SKHCY, NAS:WOOF, OTCPK:CAKFY, NYSE:EVHC, NAS:ACHC, NYSE:HLS, NYSE:CHE, OTCPK:LTGHY, NAS:LPNT, OTCPK:RMSYF, NAS:SCAI, NYSE:THC, NYSE:AMN, NYSE:SEM, NAS:AMED, NYSE:UHS, NAS:PAHC, NAS:SGRY, NYSE:CYH, NAS:TVTY » details
Traded in other countries:PDC.Germany, MD.Mexico,
Mednax Inc is a provider of physician services including newborn, maternal-fetal, pediatric subspecialties, and anesthesia care.

Mednax Inc was incorporated in Florida in 2007 and is the successor to Pediatrix Medical Group, Inc., which was incorporated in Florida in 1979. The Company is a provider of physician services including Neonatal Care, Maternal-fetal Care, Pediatric Cardiology Care, Other Pediatric Subspecialty Care and Anesthesia Care. The Company's national network comprised over 3,240 affiliated physicians, including over 1,100 physicians who provide neonatal clinical care, in 35 states and Puerto Rico, primarily within hospital-based neonatal intensive care units ("NICUs"), to babies born prematurely or with medical complications. The Company over 1,150 affiliated physicians who provide anesthesia care to patients in connection with surgical and other procedures, as well as pain management. In addition, it has over 255 affiliated physicians who provide maternal-fetal and obstetrical medical care to expectant mothers experiencing complicated pregnancies primarily in areas where its affiliated neonatal physicians practice. The Company's network includes other pediatric subspecialists, including approximately 145 physicians providing pediatric intensive care, 120 physicians providing pediatric cardiology care, 100 physicians providing hospital-based pediatric care and 20 physicians providing pediatric surgical care. The Company provides clinical care to babies born prematurely or with complications within specific units at hospitals, mainly NICUs, through a team of experienced neonatal physician subspecialists called neonatologists, neonatal nurse practitioners and other pediatric clinicians. The Company provides outpatient and inpatient clinical care to expectant mothers and their unborn babies through its affiliated maternal-fetal medicine subspecialists, obstetricians and other clinicians, such as maternal-fetal nurse practitioners, certified nurse mid-wives, ultrasonographers and genetic counselors. It provides inpatient and outpatient pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease as well as adults with congenital heart defects through its affiliated pediatric cardiologist subspecialists and other clinicians such as pediatric nurse practitioners, echocardiographers and other diagnostic technicians, and exercise physiologists. Its network includes pediatric intensivists, who are hospital-based pediatricians with additional education and training in caring for critically ill or injured children and adolescents, and pediatric hospitalists, who are hospital-based pediatricians specializing in inpatient care and management of acutely ill children. The Company provides anesthesia care through a team of experienced physician anesthesiologists, certified registered nurse anesthetists and anesthesia assistants. It has physicians who provide maternal-fetal medical care to expectant mothers experiencing complicated pregnancies and obstetricians hospitalize services

Ratios

vs
industry
vs
history
PE Ratio 20.57
MD's PE Ratio is ranked higher than
62% of the 160 Companies
in the Global Medical Care industry.

( Industry Median: 25.10 vs. MD: 20.57 )
Ranked among companies with meaningful PE Ratio only.
MD' s PE Ratio Range Over the Past 10 Years
Min: 6.95  Med: 18.12 Max: 26.73
Current: 20.57
6.95
26.73
PE Ratio without NRI 20.57
MD's PE Ratio without NRI is ranked higher than
65% of the 159 Companies
in the Global Medical Care industry.

( Industry Median: 25.91 vs. MD: 20.57 )
Ranked among companies with meaningful PE Ratio without NRI only.
MD' s PE Ratio without NRI Range Over the Past 10 Years
Min: 8.01  Med: 18.25 Max: 27.01
Current: 20.57
8.01
27.01
Price-to-Owner-Earnings 17.41
MD's Price-to-Owner-Earnings is ranked higher than
76% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 27.14 vs. MD: 17.41 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
MD' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 5.51  Med: 16.03 Max: 23.37
Current: 17.41
5.51
23.37
PB Ratio 2.44
MD's PB Ratio is ranked lower than
51% of the 192 Companies
in the Global Medical Care industry.

( Industry Median: 2.40 vs. MD: 2.44 )
Ranked among companies with meaningful PB Ratio only.
MD' s PB Ratio Range Over the Past 10 Years
Min: 1.23  Med: 2.33 Max: 3.59
Current: 2.44
1.23
3.59
PS Ratio 2.09
MD's PS Ratio is ranked lower than
65% of the 206 Companies
in the Global Medical Care industry.

( Industry Median: 1.46 vs. MD: 2.09 )
Ranked among companies with meaningful PS Ratio only.
MD' s PS Ratio Range Over the Past 10 Years
Min: 1.13  Med: 2.33 Max: 3.83
Current: 2.09
1.13
3.83
Price-to-Free-Cash-Flow 16.57
MD's Price-to-Free-Cash-Flow is ranked higher than
68% of the 94 Companies
in the Global Medical Care industry.

( Industry Median: 23.37 vs. MD: 16.57 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
MD' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 6.38  Med: 14.78 Max: 20.76
Current: 16.57
6.38
20.76
Price-to-Operating-Cash-Flow 15.10
MD's Price-to-Operating-Cash-Flow is ranked lower than
56% of the 135 Companies
in the Global Medical Care industry.

( Industry Median: 13.84 vs. MD: 15.10 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
MD' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 5.86  Med: 13.76 Max: 19.7
Current: 15.1
5.86
19.7
EV-to-EBIT 14.54
MD's EV-to-EBIT is ranked higher than
71% of the 145 Companies
in the Global Medical Care industry.

( Industry Median: 19.61 vs. MD: 14.54 )
Ranked among companies with meaningful EV-to-EBIT only.
MD' s EV-to-EBIT Range Over the Past 10 Years
Min: 5.2  Med: 11.8 Max: 16.9
Current: 14.54
5.2
16.9
EV-to-EBITDA 12.59
MD's EV-to-EBITDA is ranked higher than
61% of the 157 Companies
in the Global Medical Care industry.

( Industry Median: 14.11 vs. MD: 12.59 )
Ranked among companies with meaningful EV-to-EBITDA only.
MD' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5  Med: 11 Max: 15.6
Current: 12.59
5
15.6
PEG Ratio 1.47
MD's PEG Ratio is ranked higher than
78% of the 85 Companies
in the Global Medical Care industry.

( Industry Median: 2.76 vs. MD: 1.47 )
Ranked among companies with meaningful PEG Ratio only.
MD' s PEG Ratio Range Over the Past 10 Years
Min: 0.62  Med: 1.32 Max: 2.09
Current: 1.47
0.62
2.09
Shiller PE Ratio 27.35
MD's Shiller PE Ratio is ranked higher than
60% of the 45 Companies
in the Global Medical Care industry.

( Industry Median: 30.81 vs. MD: 27.35 )
Ranked among companies with meaningful Shiller PE Ratio only.
MD' s Shiller PE Ratio Range Over the Past 10 Years
Min: 13.06  Med: 26.13 Max: 42.09
Current: 27.35
13.06
42.09
Current Ratio 1.31
MD's Current Ratio is ranked higher than
58% of the 201 Companies
in the Global Medical Care industry.

( Industry Median: 1.20 vs. MD: 1.31 )
Ranked among companies with meaningful Current Ratio only.
MD' s Current Ratio Range Over the Past 10 Years
Min: 0.83  Med: 1.22 Max: 2.54
Current: 1.31
0.83
2.54
Quick Ratio 1.31
MD's Quick Ratio is ranked higher than
62% of the 201 Companies
in the Global Medical Care industry.

( Industry Median: 1.07 vs. MD: 1.31 )
Ranked among companies with meaningful Quick Ratio only.
MD' s Quick Ratio Range Over the Past 10 Years
Min: 0.83  Med: 1.22 Max: 2.54
Current: 1.31
0.83
2.54
Days Sales Outstanding 56.79
MD's Days Sales Outstanding is ranked lower than
71% of the 170 Companies
in the Global Medical Care industry.

( Industry Median: 44.02 vs. MD: 56.79 )
Ranked among companies with meaningful Days Sales Outstanding only.
MD' s Days Sales Outstanding Range Over the Past 10 Years
Min: 46.59  Med: 52.83 Max: 58.39
Current: 56.79
46.59
58.39
Days Payable 4.83
MD's Days Payable is ranked lower than
94% of the 131 Companies
in the Global Medical Care industry.

( Industry Median: 38.57 vs. MD: 4.83 )
Ranked among companies with meaningful Days Payable only.
MD' s Days Payable Range Over the Past 10 Years
Min: 3.59  Med: 4.52 Max: 7.33
Current: 4.83
3.59
7.33

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio 2.60
MD's 3-Year Average Share Buyback Ratio is ranked higher than
90% of the 123 Companies
in the Global Medical Care industry.

( Industry Median: -2.50 vs. MD: 2.60 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
MD' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -17.5  Med: -1 Max: 3.4
Current: 2.6
-17.5
3.4

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 0.91
MD's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
79% of the 96 Companies
in the Global Medical Care industry.

( Industry Median: 1.76 vs. MD: 0.91 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
MD' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.5  Med: 1.01 Max: 2.48
Current: 0.91
0.5
2.48
Price-to-Intrinsic-Value-DCF (Earnings Based) 1.26
MD's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked higher than
83% of the 30 Companies
in the Global Medical Care industry.

( Industry Median: 1.84 vs. MD: 1.26 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
N/A
Price-to-Median-PS-Value 0.90
MD's Price-to-Median-PS-Value is ranked higher than
72% of the 179 Companies
in the Global Medical Care industry.

( Industry Median: 1.04 vs. MD: 0.90 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
MD' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.21  Med: 0.99 Max: 2.18
Current: 0.9
0.21
2.18
Price-to-Peter-Lynch-Fair-Value 1.41
MD's Price-to-Peter-Lynch-Fair-Value is ranked higher than
72% of the 46 Companies
in the Global Medical Care industry.

( Industry Median: 2.32 vs. MD: 1.41 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
MD' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.09  Med: 1.34 Max: 3.37
Current: 1.41
0.09
3.37
Earnings Yield (Greenblatt) % 6.86
MD's Earnings Yield (Greenblatt) % is ranked higher than
77% of the 185 Companies
in the Global Medical Care industry.

( Industry Median: 4.10 vs. MD: 6.86 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
MD' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 5.9  Med: 8.4 Max: 19.1
Current: 6.86
5.9
19.1
Forward Rate of Return (Yacktman) % 19.88
MD's Forward Rate of Return (Yacktman) % is ranked higher than
76% of the 116 Companies
in the Global Medical Care industry.

( Industry Median: 10.28 vs. MD: 19.88 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
MD' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 14.8  Med: 19.4 Max: 25.5
Current: 19.88
14.8
25.5

More Statistics

Revenue (TTM) (Mil) $3,183
EPS (TTM) $ 3.50
Beta0.25
Short Percentage of Float10.25%
52-Week Range $59.36 - 76.96
Shares Outstanding (Mil)93.79

Analyst Estimate

Dec17
Revenue (Mil $)
EPS ($) 4.58
EPS without NRI ($) 4.58
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)
» More Articles for MD

Headlines

Articles On GuruFocus.com
5 Positions With Great Returns in 2015 Jan 03 2016 
Weekly CEO Sells Highlight Sep 06 2015 
MEDNAX Inc. -- Only 10% Growth Last Week?! Nov 02 2014 
Groups of Gurus Hold 10-Year Low P/B Stocks - ATVI, CHL, MD Dec 20 2013 
5 Inexpensive Stocks for Your Portfolio Jan 19 2012 
Mednax, a Quality Healthcare Stock to Consider Oct 18 2011 
MEDNAX, INC. (MD) COO / Pediatrix Division David A. Clark sells 7,456 Shares Dec 10 2010 
MEDNAX, INC. (MD) COO / Pediatrix Division David A. Clark sells 2,960 Shares Dec 03 2010 
MEDNAX, INC. (MD) CFO Vivian Lopez-blanco sells 1,850 Shares Nov 05 2010 
MEDNAX, INC. Reports Operating Results (10-Q) Nov 03 2010 

More From Other Websites
Watson Health Medical Imaging Collaborative Expands to 24 Members; IBM Debuts Watson Imaging... Feb 27 2017
MEDNAX to Present at Upcoming Investor Conferences Feb 23 2017
Watson Health Medical Imaging Collaborative Expands to 24 Members; IBM Debuts Watson Clinical... Feb 20 2017
MEDNAX, INC. Financials Feb 16 2017
MEDNAX, INC. Files SEC form 10-K, Annual Report Feb 10 2017
MEDNAX, Inc. :MD-US: Earnings Analysis: 2016 By the Numbers : February 9, 2017 Feb 09 2017
MEDNAX, Inc. :MD-US: Earnings Analysis: Q4, 2016 By the Numbers : February 8, 2017 Feb 08 2017
Edited Transcript of MD earnings conference call or presentation 7-Feb-17 3:00pm GMT Feb 07 2017
MEDNAX Inc Earnings Call scheduled for 10:00 am ET today Feb 07 2017
Q4 2016 MEDNAX Inc Earnings Release - Before Market Open Feb 07 2017
MEDNAX, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Feb 07 2017
Mednax misses Street 4Q forecasts Feb 07 2017
Mednax misses Street 4Q forecasts Feb 07 2017
MEDNAX Reports Fourth Quarter GAAP EPS of $0.84; Adjusted EPS of $1.00 Feb 07 2017
Healthcare Stock Q4 Earnings Slated on Feb 7: CNC, WCG, MD Feb 06 2017
MEDNAX Announces Acquisition of Multi-Specialty Practice in Texas Feb 06 2017
Mednax buys its first radiology practice Jan 30 2017
MEDNAX Announces First Acquisition of Radiology Practice Jan 30 2017
MEDNAX Announces Acquisition of Neonatology Practice in Utah Jan 25 2017
MEDNAX’s American Anesthesiology to Exhibit at PRACTICE MANAGEMENT 2017 Jan 23 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)